Copyright Reports & Markets. All rights reserved.

Global Hepatitis C Virus (HCV) Antiviral Market Research Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Hepatitis C Virus (HCV) Antiviral Market Overview

      • 1.1 Product Overview and Scope of Hepatitis C Virus (HCV) Antiviral
      • 1.2 Hepatitis C Virus (HCV) Antiviral Segment by Type
        • 1.2.1 Global Hepatitis C Virus (HCV) Antiviral Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 HCV Antibody
        • 1.2.3 HCV Viral Load
        • 1.2.4 HCV Genotyping
      • 1.3 Hepatitis C Virus (HCV) Antiviral Segment by Application
        • 1.3.1 Hepatitis C Virus (HCV) Antiviral Consumption Comparison by Application (2014-2025)
        • 1.3.2 Diagnostic Centers
        • 1.3.3 Hospitals
        • 1.3.4 Home Use
      • 1.4 Global Hepatitis C Virus (HCV) Antiviral Market by Region
        • 1.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Hepatitis C Virus (HCV) Antiviral Market Size
        • 1.5.1 Global Hepatitis C Virus (HCV) Antiviral Revenue (2014-2025)
        • 1.5.2 Global Hepatitis C Virus (HCV) Antiviral Production (2014-2025)

      2 Global Hepatitis C Virus (HCV) Antiviral Market Competition by Manufacturers

      • 2.1 Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Hepatitis C Virus (HCV) Antiviral Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Hepatitis C Virus (HCV) Antiviral Production Sites, Area Served, Product Types
      • 2.5 Hepatitis C Virus (HCV) Antiviral Market Competitive Situation and Trends
        • 2.5.1 Hepatitis C Virus (HCV) Antiviral Market Concentration Rate
        • 2.5.2 Hepatitis C Virus (HCV) Antiviral Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Regions

      • 3.1 Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Regions
      • 3.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Hepatitis C Virus (HCV) Antiviral Production
        • 3.4.1 North America Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2014-2019)
        • 3.4.2 North America Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Hepatitis C Virus (HCV) Antiviral Production
        • 3.5.1 Europe Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2014-2019)
        • 3.5.2 Europe Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Hepatitis C Virus (HCV) Antiviral Production (2014-2019)
        • 3.6.1 China Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2014-2019)
        • 3.6.2 China Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Hepatitis C Virus (HCV) Antiviral Production (2014-2019)
        • 3.7.1 Japan Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2014-2019)
        • 3.7.2 Japan Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Hepatitis C Virus (HCV) Antiviral Consumption by Regions

      • 4.1 Global Hepatitis C Virus (HCV) Antiviral Consumption by Regions
      • 4.2 North America Hepatitis C Virus (HCV) Antiviral Consumption (2014-2019)
      • 4.3 Europe Hepatitis C Virus (HCV) Antiviral Consumption (2014-2019)
      • 4.4 China Hepatitis C Virus (HCV) Antiviral Consumption (2014-2019)
      • 4.5 Japan Hepatitis C Virus (HCV) Antiviral Consumption (2014-2019)

      5 Global Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price Trend by Type

      • 5.1 Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Type (2014-2019)
      • 5.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2014-2019)
      • 5.3 Global Hepatitis C Virus (HCV) Antiviral Price by Type (2014-2019)
      • 5.4 Global Hepatitis C Virus (HCV) Antiviral Production Growth by Type (2014-2019)

      6 Global Hepatitis C Virus (HCV) Antiviral Market Analysis by Applications

      • 6.1 Global Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Application (2014-2019)
      • 6.2 Global Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Hepatitis C Virus (HCV) Antiviral Business

      • 7.1 Roche Diagnostics
        • 7.1.1 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.1.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Abbott
        • 7.2.1 Abbott Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.2.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Siemens
        • 7.3.1 Siemens Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.3.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Qiagen
        • 7.4.1 Qiagen Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.4.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 bioMérieux
        • 7.5.1 bioMérieux Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.5.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Bio-Rad Laboratories
        • 7.6.1 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.6.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Meridian Bioscience
        • 7.7.1 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.7.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Vista Diagnostics
        • 7.8.1 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.8.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Biogate Laboratories
        • 7.9.1 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.9.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 J.Mitra & Co. Ltd
        • 7.10.1 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Production Sites and Area Served
        • 7.10.2 Hepatitis C Virus (HCV) Antiviral Product Introduction, Application and Specification
        • 7.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Siemens Medical
      • 7.12 General Biologicals

      8 Hepatitis C Virus (HCV) Antiviral Manufacturing Cost Analysis

      • 8.1 Hepatitis C Virus (HCV) Antiviral Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Hepatitis C Virus (HCV) Antiviral
      • 8.4 Hepatitis C Virus (HCV) Antiviral Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Hepatitis C Virus (HCV) Antiviral Distributors List
      • 9.3 Hepatitis C Virus (HCV) Antiviral Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Hepatitis C Virus (HCV) Antiviral Market Forecast

      • 11.1 Global Hepatitis C Virus (HCV) Antiviral Production, Revenue Forecast
        • 11.1.1 Global Hepatitis C Virus (HCV) Antiviral Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Hepatitis C Virus (HCV) Antiviral Price and Trend Forecast (2019-2025)
      • 11.2 Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Hepatitis C Virus (HCV) Antiviral Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Hepatitis C Virus (HCV) Antiviral Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Hepatitis C Virus (HCV) Antiviral Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Hepatitis C Virus (HCV) Antiviral Production, Revenue Forecast (2019-2025)
      • 11.3 Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Hepatitis C Virus (HCV) Antiviral Consumption Forecast (2019-2025)
        • 11.3.2 Europe Hepatitis C Virus (HCV) Antiviral Consumption Forecast (2019-2025)
        • 11.3.3 China Hepatitis C Virus (HCV) Antiviral Consumption Forecast (2019-2025)
        • 11.3.4 Japan Hepatitis C Virus (HCV) Antiviral Consumption Forecast (2019-2025)
      • 11.4 Global Hepatitis C Virus (HCV) Antiviral Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.

        The global Hepatitis C Virus (HCV) Antiviral market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Hepatitis C Virus (HCV) Antiviral volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatitis C Virus (HCV) Antiviral market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Roche Diagnostics
        Abbott
        Siemens
        Qiagen
        bioMérieux
        Bio-Rad Laboratories
        Meridian Bioscience
        Vista Diagnostics
        Biogate Laboratories
        J.Mitra & Co. Ltd
        Siemens Medical
        General Biologicals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        HCV Antibody
        HCV Viral Load
        HCV Genotyping

        Segment by Application
        Diagnostic Centers
        Hospitals
        Home Use

        Buy now